AB0410 COMPARISON OF ON-LABEL TREATMENT PERSISTENCE IN REAL-WORLD PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING GUSELKUMAB VERSUS SUBCUTANEOUS TNF INHIBITORS

Shiff N.J.,Walsh J.A.,Lin I., Zhao R., Morrison L.,Emond B., Yu L.H., Schwartzbein S., Lefebvre P.,Pilon D.,Chakravarty S.D.,Mease P.J.

Annals of the Rheumatic Diseases（2024）

Cited 0|Views0

Key words

Real-world evidence,Disease-modifying Drugs (DMARDs)

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined